Recently, FAP-targeted positron emission tomography (PET) imaging using a FAP inhibitor (FAPI) has been described as a non-invasive sensitive tool for advanced tumor staging and monitoring and has a promising potential owing to its ability to accurately depict most malignant tumors (30). This evidence concerns the gene FAP and neoplasm.